“Genetron Health leads in companion diagnostics, with our co-developed ‘PDGFRA Gene D842V Mutation Detection Kit’ becoming China's first NMPA-approved kit using global data. This milestone advances our global precision medicine reach, benefiting more patients worldwide.”
CHIEF MEDICAL OFFICER, GENETRON HEALTH
In 2020, Dr. Yunfu Hu (former Deputy Director of the FDA Center for Medical Devices and Radiological Health (CDRH)/Office of In-Vitro Diagnostic and Radiological Health (OIR)) joined Genetron Health as its CMO. During his FDA tenure, Dr. Hu oversaw the approval process for a number of the world’s first companion diagnostic products. His joining in Genetron Health further strengthened our scientific research and product transformation capabilities.
01
Genetron Health’s diversified platform features innovative patented technologies such as the “One-Step Seq Method” and a nationwide marketing network, enabling our veteran registry team to provide clients with R&D of integrated companion diagnostic products and commercialization services.
.png)
02
We offer a seamless one-stop solution for partners, encompassing clinical trial consulting, precision patient enrollment, and genomics testing that meets international standards like CAP, CLIA, ISO 15189. Our services also include robust data analysis, addressing all facets of drug development.
.png)
03
Genetron Health’s big data platform enables precision testing for early stage research and targeted screening solutions for patients covered by our biopharma partners. Our team provides industry-leading expertise and support for new drug development and validation.
